Renalytix - Current Ratio 2020-2024 | RNLXY
Renalytix - current ratio from 2020 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Renalytix - Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $0.00B | $0.01B | 0.24 |
| 2024-06-30 | $0.01B | $0.01B | 0.53 |
| 2024-03-31 | $0.01B | $0.02B | 0.42 |
| 2023-12-31 | $0.01B | $0.01B | 0.59 |
| 2023-09-30 | $0.02B | $0.02B | 1.09 |
| 2023-06-30 | $0.03B | $0.02B | 1.67 |
| 2023-03-31 | $0.04B | $0.02B | 2.43 |
| 2022-12-31 | $0.03B | $0.01B | 1.86 |
| 2022-09-30 | $0.03B | $0.01B | 2.58 |
| 2022-06-30 | $0.05B | $0.01B | 3.80 |
| 2022-03-31 | $0.04B | $0.02B | 2.48 |
| 2021-12-31 | $0.04B | $0.01B | 5.20 |
| 2021-09-30 | $0.06B | $0.01B | 7.76 |
| 2021-06-30 | $0.07B | $0.01B | 9.46 |
| 2021-03-31 | $0.07B | $0.01B | 13.90 |
| 2020-12-31 | $0.08B | $0.00B | 21.20 |
| 2020-09-30 | $0.09B | $0.00B | 22.75 |
| 2020-06-30 | $0.02B | $0.00B | 4.51 |
| 2020-03-31 | $0.00B | 0.00 | |
| 2019-12-31 | $0.00B | 0.00 | |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.01B | $0.00B | 8.20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.031B | $0.002B |
| Renalytix plc is an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care. Renalytix plc, formerly known as RENALYTIX AI, is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.177B | 57.48 |
| Doximity (DOCS) | United States | $11.570B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.189B | 116.26 |
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.774B | 58.97 |
| Hinge Health (HNGE) | United States | $3.628B | 0.00 |
| Privia Health (PRVA) | United States | $2.525B | 172.58 |
| Enovis (ENOV) | United States | $1.763B | 9.83 |
| Schrodinger (SDGR) | United States | $1.589B | 0.00 |
| Phreesia (PHR) | United States | $1.543B | 0.00 |
| 10x Genomics (TXG) | United States | $1.533B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.532B | 0.00 |
| Azenta (AZTA) | United States | $1.470B | 68.32 |
| Evolent Health (EVH) | United States | $1.323B | 112.70 |
| Omnicell (OMCL) | United States | $1.310B | 23.12 |
| Claritev (CTEV) | United States | $0.733B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.552B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.457B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.328B | 728.33 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.282B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| CapsoVision (CV) | United States | $0.218B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.107B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |